SiegelRLMillerKDJemalA. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
2.
O’ConnorETimmBLawrentschukNIschiaJ. Open partial nephrectomy: current review. Transl Androl Urol. 2020;9(6):3149–3159.
3.
CampellSCClarkPEChangSS, et al.Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline part I. J Urol. 2021;206:199.
4.
CampbellSCUzzoRGKaramJA, et al.Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II. J Urol. 2021;206:209.
5.
TelliniRAntonelliATardanicoR, et al.Positive surgical margins predict progression-free survival after nephron-sparing surgery for renal cell carcinoma: results from a single center cohort of 459 cases with a Minimum follow-up of 5 years. Clin Genitourin Cancer. 2019;17(1):e26–e31.
6.
BertoloRNicolasMGaristoJMagi-GalluzziCMcKenneyJKKaoukJ. Low rate of cancer events after partial nephrectomy for renal cell carcinoma: clinicopathologic analysis of 1994 cases with emphasis on definition of “recurrence”. Clin Genitourin Cancer. 2019;17(3):209–215.e1.
BaniakNFloodTABuchananMDal CinPHirschMS. Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes. Histopathology. 2020;77(4):659–666.
9.
GradeckiSEValdes-RodriguezRWickMRGruAA. PRAME Immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna. Histopathology. 2021;78(7):1000–1008.
